Biographies of the Directors Follow:
Alan Reade (Executive Chairman) was appointed on 25 May
2007 as Non-executive Director. He is the owner of Global
Strategy Expression Limited, a consulting and advisory services
business in the life sciences industry. From 2000 until his
retirement in 2005, he served as executive chairman of Merial
Limited, a leading animal health company and joint venture
between Merck & Co. Inc. and Sanofi-A ventis. Earlier in his
career he was head of global integration at Aventis, where he
was in charge of merger integration, and Chief Executive
Officer and member of the Global Executive Committee at
Rhone-Poulenc Inc. He previously has been a director of Sygen
International and IFAH , a global animal health association as
well as more than 40 Merial subsidiaries. He was chairman
of the Remuneration Committee until his appointment as
executive Chairman and member of the Nomination Committee
throughout the year. Subsequent to the year end, on
4 January 2010 he was appointed as Executive Chairman.
Barry Riley (Non-executive Director) was appointed on 25 May
2007. After qualifying as a Chartered Accountant, he joined
the Bowater Organization, where he had responsibility for the
finance function at several operations. From there he moved
to FMC Corporation, the US conglomerate where he had
finance and general management responsibilities for a specialty
chemical operation, and also oversaw the head office
finance function for all UK operations. He joined Proteus
International plc in 1995 as Finance Director and was closely
involved in the merger with Therapeutic Antibodies Inc. in
1999, which became Protherics plc where he was Finance
Director until 2007. He is chairman of the Audit Committee
and a member of the Nomination and Remuneration Committee
and is also the Senior Independent Director.
Patrick Regan (Non-executive Director) was appointed on
16 September 2009. He brings to the Board over sixteen
years of financial analysis, corporate management, investment
banking and venture capital experience gained in the US .
Mr. Regan has been a senior managing director for Laurus
Capital Management LLC since 2001 and has also served
the same role at Valens Capital Management LLC since its
establishment in 2007. In addition to his fund management
experience
at Laurus-V alens, he has spent four years as a
financial analyst at Geller & Company. At Geller, he was
involved in private placement financing, management consulting
and general corporate finance functions. Between
1999 and 2001, Patrick Regan was an associate at Tower
Hill Capital Group, an investment banking boutique and
venture capital firm. Mr. Regan resigned from the board on
27 May 2011.
James Hills (Non-executive Director) was appointed on 9 July
2010. Mr. Hills spent the early portion of his career with The
Gillette Company and Coca Cola USA where he held senior
positions in both sales and brand management. Later, he
became a 50% partner and Chief Executive Officer of
Weatherly Consumer Products Inc. (Jobe's), a company which
developed, branded and marketed specialty fertilizers in
North America and Europe. Following the sale of that business
in 1996, he and a partner started Gulfstream Home
and Garden, a company that marketed consumer insecticides
for the lawn and garden market in the U.S. Mr. Hills sold
Gulfstream in 2005, following nearly ten years of rapid growth.
He is chairman of the Remuneration Committee and a member
of the Audit and Nomination Committees.
Dir ectors' Interests
The directors at 31 December 2010 and their beneficial interests
in the share capital of the Group, other than with respect
to options to acquire ordinary shares (which are detailed in the
analysis of options included in the Directors' Remuneration
Report) are as follows:
31 December 2010
(or earlier date
of resignation)
Common Shares of
US $0.001 each
1 January 2010
(or later date
of appointment)
Common Shares of
US $0.001 each
G.N. Vernon Nil Nil
R.D. Armstrong Nil 543,059
K.E. Bigsby Nil 172,161
A.J. Reade 4,071,808 69,200
B.M. Riley 1,255,556 Nil
K.D. Noonan Nil Nil
P. Regan 566,674 Nil
J. Hills Nil Nil
17
T y r a T e c h , I n c . : A n n u a l R e p o rt 2 0 1 0
